- Home
- MGTX vs BTQ Comparison
MGTX vs BTQ Comparison
Compare MGTX & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- BTQ
- Stock Information
- Founded
- MGTX 2015
- BTQ 1983
- Country
- MGTX United States
- BTQ Canada
- Employees
- MGTX N/A
- BTQ N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- BTQ
- Sector
- MGTX Health Care
- BTQ
- Exchange
- MGTX Nasdaq
- BTQ Nasdaq
- Market Cap
- MGTX 670.2M
- BTQ 728.0M
- IPO Year
- MGTX N/A
- BTQ N/A
- Fundamental
- Price
- MGTX $8.76
- BTQ $12.55
- Analyst Decision
- MGTX Strong Buy
- BTQ
- Analyst Count
- MGTX 2
- BTQ 0
- Target Price
- MGTX $24.00
- BTQ N/A
- AVG Volume (30 Days)
- MGTX 378.1K
- BTQ 6.3M
- Earning Date
- MGTX 11-12-2025
- BTQ 11-14-2025
- Dividend Yield
- MGTX N/A
- BTQ N/A
- EPS Growth
- MGTX N/A
- BTQ N/A
- EPS
- MGTX N/A
- BTQ N/A
- Revenue
- MGTX $37,917,000.00
- BTQ $653,726.00
- Revenue This Year
- MGTX $144.79
- BTQ $100.70
- Revenue Next Year
- MGTX $168.58
- BTQ $669.96
- P/E Ratio
- MGTX N/A
- BTQ N/A
- Revenue Growth
- MGTX 366.84
- BTQ 884.39
- 52 Week Low
- MGTX $3.97
- BTQ $0.18
- 52 Week High
- MGTX $8.98
- BTQ $16.00
- Technical
- Relative Strength Index (RSI)
- MGTX 67.02
- BTQ N/A
- Support Level
- MGTX $8.20
- BTQ N/A
- Resistance Level
- MGTX $8.68
- BTQ N/A
- Average True Range (ATR)
- MGTX 0.41
- BTQ 0.00
- MACD
- MGTX 0.05
- BTQ 0.00
- Stochastic Oscillator
- MGTX 87.54
- BTQ 0.00
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.